Clinical Trials Directory

Trials / Completed

CompletedNCT01969617

Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge

Interventional, Randomized, Double-blind, Cross-over, Placebo-controlled Study to Investigate the Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
22 (actual)
Sponsor
H. Lundbeck A/S · Industry
Sex
Male
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To contribute to the understanding of the underlying neurobiological mechanism behind the interaction of alcohol and nalmefene

Conditions

Interventions

TypeNameDescription
DRUGNalmefene 18 mg, then placeboOne single oral dose Nalmefene on Day 1 and Placebo on Day 8
DRUGPlacebo, then Nalmefene 18 mgOne single oral dose Placebo on Day 1 and Nalmefene on Day 8

Timeline

Start date
2013-11-01
Primary completion
2014-10-01
First posted
2013-10-25
Last updated
2014-11-11

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01969617. Inclusion in this directory is not an endorsement.